姓名：尤红 性别：女 职称：研究员、教授 招生院所：附属友谊医院 招生类型：科学与专业学位(博) 科学与专业学位(硕) 招生专业：中西医结合临床医学(博) 中西医结合临床(硕) 研究方向名称：肝纤维化的基础和临床研究 电子信箱：youhong30@sina.com


社会任职
1. 中华肝脏病杂志 编委
2. American Journal of Physiology-Gastrointestinal and Liver Physiology 编委
3. Journal of Medical Virology 副主编
4. 国际肝脏病理Laennec组织 中国大陆成员
5. 中华医学会肝病学分会临床流行病学与循证医学协作组 组长
6. 亚太肝病学会（APASL）执行委员
7. 中华医学会肝病学分会 副主任委员
个人简历
1. 198908-199406:首都医科大学临床医学系 本科
2. 199409-199907:首都医科大学内科（消化） 博士（硕博连读）
3. 199907-200011:首都医科大学附属北京友谊医院肝病中心 助理研究员
4. 200011-200311:美国阿肯色州立医科大学基因治疗中心 博士后
5. 200312-201011:首都医科大学附属北京友谊医院肝病中心 副研究员
6. 201011-:首都医科大学附属北京友谊医院肝病中心 研究员
7. 201111-:首都医科大学附属北京友谊医院肝病中心 教授，主任医师
8. 201512-:首都医科大学附属北京友谊医院肝病实验中心 院长助理
9. 201606-:首都医科大学附属北京友谊医院肝病实验中心 院长助理，科技处处长，实验中心主任
重要学术论文
1. Sun Y, Wu X, Zhou J, Meng T, Wang B, Chen S, Liu H, Wang T, Zhao X, Wu S, Kong Y, Ou X, Wee A, Theise ND, Qiu C, Zhang W, Lu F, Jia J, You H*..Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy.. Clin Gastroenterol Hepatol. 2020,【未填写卷（期）】:【未填写起止页码】.SCI
2. Wei Chen, Aiting Yang, Jidong Jia, Yury V Popov, Detlef Schuppan*, Hong You*.Lysyl oxidase (LOX) family members: rationale and their potential as therapeutic targets for liver fibrosis. Hepatology. 2020,【未填写卷（期）】:【未填写起止页码】.SCI
3. Liu T, Sun Y, Zhou J, Yang F, Zou X, Wang L, Wu X, Chen Y, Piao H, Lu L, Jiang W, Xu Y, Feng B, Nan Y, Xie W, Chen G, Zheng H, Li H, Ding H, Liu H, Wang T, Ou X, Wu S, Kong Y, Wang P, Cong M, Zhang Y, You H*, Jia J*..On-treatment changes of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein are associated with the regression of liver fibrosis in chronic hepatitis B patients on interferon α add-on therapy. . J Med Virol. 2019,91(8):1499-1509.SCI
4. "Kong Y, Sun Y, Zhou J, Wu X, Chen Y, Piao H, Lu L, Ding H, Nan Y, Jiang W, Xu .Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir. . J Viral Hepat. 2019,26(5):576-585.SCI
5. Wang B, Sun Y, Zhou J, Wu X, Chen S, Shi Y, Wu S, Liu H, Ren Y, Ou X, Jia J, You H*..SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies. . Hepatol Int. 2019,13(4):501-509.SCI
6. She S#, Wu X#, Zheng D, Pei X, Ma J, Sun Y, Zhou J, Nong L, Guo C, Lv P, Song Q, Zheng C, Liang W, Huang S, Li Q, Liu Z, Song Z, Li Y, Zhang Y, Kong W, You H*, Xi J*, Wang Y*..PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target.. J Hepatol. 2019,72(3):506-518.SCI
7. Wu S, Kong Y, Piao H, Jiang W, Xie W, Chen Y, Lu L, Ma A, Xie S, Ding H, Shang J, Zhang X, Feng B, Han T, Xu X, Huo L, Cheng J, Li H, Wu X, Zhou J, Sun Y, Ou X, Zhang H, You H*, Jia J*..On-treatment changes of liver stiffness at week 26 could predict 2-year clinical outcomes in HBV-related compensated cirrhosis.. Liver Int. 2018,38(6):1045-1054.SCI
8. Sun Y, Zhou J, Wu X, Chen Y, Piao H, Lu L, Ding H, Nan Y, Jiang W, Wang T, Liu H, Ou X, Wee A, Theise ND, Jia J, You H*..Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak "stable" patients on anti-HBV therapy.. Sci Rep. 2018,8(1):2989.SCI
9. Wu X#, Shi Y#, Zhou J, Sun Y, Piao H, Jiang W, Ma A, Chen Y, Xu M, Xie W, Cheng J, Xie S, Shang J, Cheng J, Xie Q, Ding H, Zhang X, Bai L, Zhang M, Wang B, Chen S, Ma H, Ou X, Jia J*, You H*..Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: A prospective multicenter randomized open-label study.. Expert Opinion on Biological Therapy. 2018,18(sup1):61-69.SCI
10. Zhao W#, Yang A, Chen W, Wang P, Liu T, Cong M, Xu A, Yan X, Jia J, You H*..Inhibition of lysyl oxidase-like 1 (LOXL1) expression arrests liver fibrosis progression in cirrhosis by reducing elastin crosslinking.. Biochimica et Biophysica Acta-Molecular Basis of Disease. 2018,1864(4 Pt A):1129-1137.SCI
11. Wu S, Yang Z, Zhou J, Zeng N, He Z, Zhan S, Jia J, You H*..Systematic review: diagnostic accuracy of non-invasive tests for staging liver fibrosis in autoimmune hepatitis.. Hepatol Int. 2018,13(1):91-101.SCI
12. Wang B, Sun Y, Zhou J, Wu X, Chen S, Wu S, Liu H, Wang T, Ou X, Jia J, You H*..Advanced septa size quantitation determines the evaluation of histological fibrosis outcome in chronic hepatitis B patients.. Mod Pathol. 2018,31(10):1567-1577.SCI
13. Chen W#, Zhao W, Yang A, Xu A, Wang H, Cong M, Liu T, Wang P, You H*..Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis.. Gene. 2017,636:87-95.SCI
14. Sun Y, Zhou J, Wang L, Wu X, Chen Y, Piao H, Lu L, Jiang W, Xu Y, Feng B, Nan Y, Xie W, Chen G, Zheng H, Li H, Ding H, Liu H, Lv F, Shao C, Wang T, Ou X, Wang B, Chen S, Wee A, Theise ND*, You H*, Jia J*..New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment.. Hepatology.. 2017,65(5):1438-1450.SCI
15. Yang AT, Hu DD, Wang P, Cong M, Liu TH, Zhang D,Sun YM, Zhao WS, Jia JD,You H*..TGF-β1 Induces the Dual Regulation of Hepatic Progenitor Cells with Both Anti- and Proliver Fibrosis. Stem Cells Int.. 2016,2016:**.SCI
16. Wang P*, Yang AT, Cong M,Liu TH, Zhang D, Huang J,Tong XF, Zhu ST, Xu Y,Tang SZ, Wang BE, Ma H, Jia JD, You H*..EGF Suppresses the Initiation and Drives the Reversion of TGF-β1-induced Transition in Hepatic Oval Cells Showing the Plasticity of Progenitor Cells.. J Cell Physiol. 2015,230(10):2362-70.SCI
17. Wu X, Jia J*, You H*..Thymosin alpha-1 treatment in chronic hepatitis B.. Expert Opin Biol Ther. 2015,2:1-4.SCI
18. Cong M, Liu T, Wang P, Fan X, Yang A, Bai Y,Peng Z, Wu P, Tong X, Chen J, Li H, Cong R, Tang S,Wang B, Jia J, You H*..Antifibrotic Effects of a Recombinant Adeno-Associated Virus Carrying Small Interfering RNA Targeting TIMP-1 in Rat Liver Fibrosis. Am J Pathol.. 2013,3:1-8.SCI
19. You H, Jia J*..Telbivudine treatment in chronic hepatitis B: experience from China.. J Viral Hepat.. 2013,Suppl 1:3-8..SCI
20. Wang P, Cong M, Liu TH, Yang AT, Cong R, Wu P, Tang SZ, Xu Y, Wang H, Wang BE, Jia JD, You H*..Primary isolated hepatic oval cells maintain progenitor cell phenotypes after two-year prolonged cultivation. J Hepatol. 2010,53(5):863-71.SCI
主编或副主编的著作/译著
1. 《《自身免疫性肝脏疾病》》,副主编,人民卫生出版社,201808
重要奖项
1. 延边朝鲜族对HCV流行病学及临床转归特点在HCV防控中的应用 吉林省科学技术奖 三等奖 201910
2. 国务院政府特殊津贴 国务院政府特殊津贴 2018
3. 乙肝相关性肝病肝移植受者抗乙肝措施应用性研究和临床结局改善 华夏医学科技奖 二等奖 201611
4. 肝纤维化防治新靶点与非创伤性诊断及干预措施的应用 中华医学科技奖 三等奖 201112
5. 肝纤维化显型表达与非创伤性诊断和临床干预 国家科学技术进步奖 二等奖 201112
6. 亚太肝病学会青年研究者奖 亚太肝病学会青年研究者奖 青年研究者奖 2008